Zobrazeno 1 - 10
of 554
pro vyhledávání: '"Ray Borrow"'
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 584-596 (2024)
Introduction Rotavirus is a leading cause of severe diarrheal disease and death in children under five years of age worldwide. Vaccination is one of the most important public health interventions to reduce this significant burden.Areas covered This l
Externí odkaz:
https://doaj.org/article/4ef3cbb2f8124cd89202124fdd3c093c
Autor:
Ray Borrow, Jamie Findlow
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 445-462 (2024)
ABSTRACTIntroduction The epidemiology of invasive meningococcal disease (IMD), a rare but potentially fatal illness, is typically described as unpredictable and subject to sporadic outbreaks.Areas covered Meningococcal epidemiology and vaccine use du
Externí odkaz:
https://doaj.org/article/c4930f5a866149acb22e48088f324df9
Autor:
Stephen A. Clark, Laura Willerton, Heike Claus, Anna Carannante, Paola Stefanelli, Raquel Abad, Julio A. Vázquez, Ray Borrow
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Factor H-Binding Protein (fHbp) is a key component of meningococcal vaccines such as MenB-fHbp, licensed in the EU, UK, and other countries. Sufficient expression of fHbp on the bacterial surface is necessary for vaccine-induced antibodies to bind an
Externí odkaz:
https://doaj.org/article/30d17cfe85f54ef29e8244af63d98a81
Autor:
Véronique Abitbol, Federico Martinón-Torres, Muhamed-Kheir Taha, Terry Nolan, Alessandro Muzzi, Stefania Bambini, Ray Borrow, Daniela Toneatto, Laura Serino, Rino Rappuoli, Mariagrazia Pizza
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
The 4-component meningococcal serogroup B (MenB) vaccine, 4CMenB, the first broadly protective, protein-based MenB vaccine to be licensed, is now registered in more than 50 countries worldwide. Real-world evidence (RWE) from the last decade confirms
Externí odkaz:
https://doaj.org/article/380746a45f9448248f21e680320ecf7a
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 226-242 (2023)
Introduction Despite children aged 6–35 months developing more severe influenza infections, not all countries include influenza vaccines in their national immunization programs. Areas covered This literature review examines the efficacy, immunogeni
Externí odkaz:
https://doaj.org/article/1d2501672f8a40429307bcf3c956a3f8
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 104-117 (2023)
Introduction Hexaxim is a hexavalent vaccine approved as primary and booster vaccination in infants 6 weeks and older, protecting against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and Haemophilus influenzae type b. Areas Covered To e
Externí odkaz:
https://doaj.org/article/dfba5fd16e6f4a79b95554600d27f68d
Autor:
Ray Borrow, Federico Martinón-Torres, Véronique Abitbol, Anar Andani, Scott Preiss, Alessandro Muzzi, Laura Serino, Woo-Yun Sohn
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 738-748 (2023)
Introduction Neisseria meningitidis serogroup B (NmB) antigens are inherently diverse with variable expression among strains. Prediction of meningococcal B (MenB) vaccine effectiveness therefore requires an assay suitable for use against large panels
Externí odkaz:
https://doaj.org/article/4e1c2a33874d4f68b50c1a9a666b28e7
Autor:
Xinchun Gu, Conall Watson, Utkarsh Agrawal, Heather Whitaker, William H. Elson, Sneha Anand, Ray Borrow, Anna Buckingham, Elizabeth Button, Lottie Curtis, Dominic Dunn, Alex J. Elliot, Filipa Ferreira, Rosalind Goudie, Uy Hoang, Katja Hoschler, Gavin Jamie, Debasish Kar, Beatrix Kele, Meredith Leston, Ezra Linley, Jack Macartney, Gemma L Marsden, Cecilia Okusi, Omid Parvizi, Catherine Quinot, Praveen Sebastianpillai, Vanashree Sexton, Gillian Smith, Timea Suli, Nicholas P B Thomas, Catherine Thompson, Daniel Todkill, Rashmi Wimalaratna, Matthew Inada-Kim, Nick Andrews, Victoria Tzortziou-Brown, Rachel Byford, Maria Zambon, Jamie Lopez-Bernal, Simon de Lusignan
Publikováno v:
JMIR Public Health and Surveillance, Vol 10, p e52047 (2024)
BackgroundPrepandemic sentinel surveillance focused on improved management of winter pressures, with influenza-like illness (ILI) being the key clinical indicator. The World Health Organization (WHO) global standards for influenza surveillance includ
Externí odkaz:
https://doaj.org/article/5c9c5cfa45c34dad908cf445ee1582a6
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionOuter membrane vesicles (OMVs) of Neisseria meningitidis in the group B-directed vaccine MenB-4C (BexseroR) protect against infections with Neisseria gonorrhoeae. The immunological basis for protection remains unclear. N. meningitidis OMV
Externí odkaz:
https://doaj.org/article/1320f61202344762a502f5f14e9d8d32
Autor:
Helen Ratcliffe, Karen S. Tiley, Stephanie Longet, Claire Tonry, Cathal Roarty, Chris Watson, Gayatri Amirthalingam, Iason Vichos, Ella Morey, Naomi L. Douglas, Spyridoula Marinou, Emma Plested, Parvinder K. Aley, Eva Galiza, Saul N. Faust, Stephen Hughes, Clare Murray, Marion R. Roderick, Fiona Shackley, Sam Oddie, Tim W.R. Lee, David P.J. Turner, Mala Raman, Stephen Owens, Paul J. Turner, Helen Cockerill, Jamie Lopez Bernal, Samreen Ijaz, John Poh, Justin Shute, Ezra Linley, Ray Borrow, Katja Hoschler, Kevin E. Brown, Miles W. Carroll, Paul Klenerman, Susanna J. Dunachie, Mary Ramsay, Merryn Voysey, Thomas Waterfield, Matthew D. Snape
Publikováno v:
iScience, Vol 26, Iss 12, Pp 108500- (2023)
Summary: SARS-CoV-2 infections in children are generally asymptomatic or mild and rarely progress to severe disease and hospitalization. Why this is so remains unclear. Here we explore the potential for protection due to pre-existing cross-reactive s
Externí odkaz:
https://doaj.org/article/d001144b1e95484bbbfeb1677546d166